Premium
Scancell Hldgs Plc (SCLP)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of ... Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2 | -8.16326530612 | 24.5 | 24.75 | 22.25 | 1239359 | 23.76793266 | DE |
| 4 | 5.75 | 34.328358209 | 16.75 | 29.5 | 16.5 | 3470399 | 22.67187427 | DE |
| 12 | 9.75 | 76.4705882353 | 12.75 | 29.5 | 11 | 2085006 | 18.56047041 | DE |
| 26 | 12.75 | 130.769230769 | 9.75 | 29.5 | 9.75 | 1785408 | 15.58019456 | DE |
| 52 | 12.75 | 130.769230769 | 9.75 | 29.5 | 7.9 | 1358787 | 13.50460881 | DE |
| 156 | 7 | 45.1612903226 | 15.5 | 29.5 | 7.25 | 952986 | 12.78396568 | DE |
| 260 | 3 | 15.3846153846 | 19.5 | 29.5 | 7.25 | 922357 | 14.95025449 | DE |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
